medigraphic.com
SPANISH

Revista Cubana de Genética Comunitaria

ISSN 2070-8718 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 3

<< Back Next >>

Rev Cub Gen 2014; 8 (3)

30th Anniversary of cytogenetic prenatal diagnosis in Havana

Méndez RLA, Morales RE, Quiñonez MO, Barrios MA, Oliva RJA, Nodarse RA, Soriano TM, García GM, Suárez MU, Molina GO, Castelvi LA, Cabrera EM, González GN, del Sol GM, Maceiras RL, Bravo ÁY
Full text How to cite this article

Language: Spanish
References: 14
Page: 7-11
PDF size: 434.88 Kb.


Key words:

cytogenetic prenatal diagnosis, Down syndrome, aneuploidy.

ABSTRACT

Cytogenetic prenatal diagnosis (CPD) is a very effective option in the diagnostic of the fetus chromosomes. This program was initiated in Havana in 1983, specifically in the Laboratory of Citogenetics. Since then several CPD modalities have been employed, such as amniocentesis, chorionic villi biopsy, cordocentesis and FISH. The purpose of this article is to evaluate the results of the Laboratory of Cytogenetics from the Havana’s National Center of Medical Genetics during these years of work. It was undertaken a retrospective descriptive study of prenatal diagnose procedures in the 1983-2012 period. There were analyzed 22 835 prenatal diagnosis from which 20 565 corresponded to amniocytes culture (AC), 1785 to chorionic villi biopsy (CVB), 385 fetal blood samples from umbilical cord (FBS) and 100 cases in interfase cells using FISH technique. In AC and CVB samples predominated the advanced maternal age indication and the percentage of positive results fluctuated between 2-3%. In FBS and FISH tests the chromosomal abnormalities detection percentage increased until 8-9%. It is necessary to introduce screening of biochemical markers in maternal serum, in order to increase the detection percentage of anomalies. Congenital Defects World Report place Cuba among the countries with lowest Down syndrome and other chromosome aberration rates, demonstrating the effectiveness and social impact of the prenatal diagnosis program.


REFERENCES

  1. 1-Quintana J, Quiñones O, Méndez LA, Lavista M, Gómez M, Dieppa N. Resultados del diagnóstico prenatal citogenético en las provincia occidentales de Cuba, 1983 -1998. Revista Cubana de Genética Humana 1999; Vol. 1( 3).

  2. 2- Quiñones O, Quintana J, Méndez L A, Barrios A, Suárez U, García M, Sol M. Frecuencias de reordenamientos cromosómicos estructurales acorde a las indicaciones para estudios citogenéticos prenatales y postnatales. Rev Cubana Genet Comunit. 2010;4(3):36-42

  3. 3-Quiñones O, Nodarse A,. Méndez LA, Román I, Hernández G, Palencia D, Suárez U. Estudios citogenéticos en muestras de sangre fetal obtenida mediante cordocentesis. Primer reporte. Rev Cubana Genet Comunit 2007;1(2):21-27

  4. 4- Méndez Rosado LA. Mosaicismo cromosómico en diagnóstico prenatal citogenético por cultivo de amniocitos. Tesis doctoral. Universidad de Ciencias Médicas de la Habana, 2010.

  5. 5- Méndez LA., Nodarse A, Morales E, Barrios A, Soriano M, Castelvi A. Diagnóstico prenatal citogenético mediante la hibridación in situ con fluorescencia. Rev. Cubana de Obstetricia y Ginecología Vol. 38 (1).2012.

  6. 6 - Ferguson-Smith MA, Yates JR. Maternal age specific rates for chromosome aberrations and factors influencing them: report of a collaborative European study on 52 965 amniocentesis. Prenat Diagn 1984 (4): 5-44.

  7. 7 - Maeda T, Ohno M, Matsunobu A, YoshiharaK, Yabe N. A cytogenetic survey of 14 835 consecutive liveborns. Jpn J Hum Genet 1991. 36: 117-129.

  8. 8 - Hook EB. Estimates of maternal age-specific risks of a Down síndrome birth in women aged 34–41. Lancet 1976. 2(7975):33–34.

  9. 9 - Khoshnood B, Pryde P, Blondel B, Lee KS.. Socioeconomic and State level differences in prenatal diagnosis and live birth prevalence of Down syndrome in the United States. Rev Epidemiol Sante Publique 2003;51:617–627.

  10. 10- Chitty L. The evolution of prenatal diagnosis Prenat Diagn 2010; 30: 599–600.

  11. 11- Wald NJ. Prenatal screening for open neural tube defects and Down syndrome: three decades of progress. Prenat Diagn 2010 30: 619–621.

  12. 12- Gardner R.J.M., Sutherland G.R.: Parental Age Counseling and Screening for Fetal Trisomy In: Chromosome abnormalities and Genetic Counselling., 3rd ed. New York, Oxford University Press, Inc., 2004, 345-371.

  13. 13-Morris JK, Waters J, de Souza E. The population impact of screening for Down syndrome: audit of 19 326 invasive diagnostic tests in England and Wales in 2008. Prenat Diagn. 2012 32(6):596-601

  14. 14- Rojas I, González RM, Padilla M, Martín M, Lavaut K, Fuentes L. Actitudes de individuos de la población cubana hacia el aborto selectivo. Rev Cubana Gen Comunit 2007;1(2):15-20. 15- WHO/HGN/GL/ETH/98.1. Proponed Internacional Guidelines on Ethical Issues in Medical Genetic and Genetic Services. Report of a WHO Meeting. Geneva: WHO offset publication;1998:p 1-16. 16- March of Dimes: Global report on Birth Defects. Christianson A., Howson CP, Modell B. March of Dimes Birth Defects Foundation, white Plains, New York.2006.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cub Gen . 2014;8